🔗 Permalink

Inventor profile of:

Curtis Wright

City:

Rockport, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2020-05-07

Top Assignees for applications by Curtis Wright

The entities that hold a legal rights for patent applications filed by inventor Wright Curtis:

Purdue Pharmaceuticals L.P. 60 Wilson, NC United States
The P.F. Laboratories, Inc. 60 Totowa, NJ United States
Purdue Pharma L.P. 44 Stamford, CT United States
Javelin Pharmaceuticals, Inc. 2 Cambridge, MA United States
THE P.F. LABORATORIES 2 Totowa, NJ United States
JAVELIN PHARMACEUTICALS, INC. 2 LAKE FOREST, IL United States
HOSPIRA, INC. 1 Lake Forest, IL United States

Recent patent applications by Wright Curtis

Curtis Wright from Rockport, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-05-07

US20200138720A1

Human necessities

Pharmaceutical formulation containing gelling agent

#2 | 2019-04-25

US20190117580A1

Human necessities

Pharmaceutical formulation containing gelling agent

#3 | 2019-04-18

US20190110996A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#4 | 2019-03-07

US20190070119A1

Human necessities

Pharmaceutical formulation containing gelling agent

#5 | 2019-01-17

US20190015341A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#6 | 2018-05-31

US20180147151A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#7 | 2018-05-10

US20180125788A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#8 | 2018-03-01

US20180055771A1

Human necessities

Pharmaceutical formulation containing gelling agent

#9 | 2018-01-25

US20180021330A1

Human necessities

PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND GELLING AGENT

#10 | 2018-01-25

US20180021262A1

Human necessities

Pharmaceutical formulation containing gelling agent

#11 | 2017-11-30

US20170340626A1

Human necessities

Oxycodone formulations

#12 | 2017-10-19

US20170296533A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#13 | 2017-06-08

US20170157115A1

Human necessities

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

#14 | 2017-04-27

US20170112765A1

Human necessities

Pharmaceutical formulation containing gelling agent

#15 | 2017-03-09

US20170065525A1

Human necessities

Pharmaceutical formulation containing gelling agent

#16 | 2017-03-09

US20170065524A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#17 | 2017-01-26

US20170020864A1

Human necessities

Pharmaceutical formulation containing gelling agent

#18 | 2017-01-26

US20170020863A1

Human necessities

Pharmaceutical formulation containing gelling agent

#19 | 2016-06-02

US20160151502A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#20 | 2016-06-02

US20160151499A1

Human necessities

Pharmaceutical formulation containing gelling agent

#21 | 2016-06-02

US20160151360A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#22 | 2016-06-02

US20160151358A1

Human necessities

Pharmaceutical formulation containing gelling agent

#23 | 2016-06-02

US20160151357A1

Human necessities

Pharmaceutical formulation containing gelling agent

#24 | 2016-06-02

US20160151356A1

Human necessities

Pharmaceutical formulation containing gelling agent

#25 | 2016-06-02

US20160151355A1

Human necessities

Pharmaceutical formulation containing gelling agent

#26 | 2016-06-02

US20160151297A1

Human necessities

Pharmaceutical formulation containing gelling agent

#27 | 2016-06-02

US20160151291A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#28 | 2016-06-02

US20160151290A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#29 | 2016-06-02

US20160151289A1

Human necessities

Pharmaceutical formulation containing gelling agent

#30 | 2016-06-02

US20160151277A1

Human necessities

Pharmaceutical formulation containing gelling agent

#31 | 2016-03-03

US20160058716A1

Human necessities

PHARMACEUTICAL FORMULATION CONTAINING GELLING AGENT

#32 | 2016-02-04

US20160030419A1

Human necessities

Oxycodone formulations

#33 | 2016-01-14

US20160008350A1

Human necessities

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

#34 | 2016-01-07

US20160000776A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#35 | 2016-01-07

US20160000723A1

Human necessities

Pharmaceutical formulation containing gelling agent

#36 | 2016-01-07

US20160000719A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#37 | 2016-01-07

US20160000718A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#38 | 2016-01-07

US20160000717A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#39 | 2016-01-07

US20160000712A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#40 | 2015-12-31

US20150374631A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#41 | 2015-12-31

US20150374628A1

Human necessities

Pharmaceutical formulation containing gelling agent

#42 | 2015-10-08

US20150283250A1

Human necessities

Pharmaceutical formulation containing gelling agent

#43 | 2015-10-08

US20150283130A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#44 | 2015-10-08

US20150283129A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#45 | 2015-10-08

US20150283128A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#46 | 2015-10-01

US20150273065A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#47 | 2015-10-01

US20150273064A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#48 | 2015-09-24

US20150265607A1

Human necessities

Pharmaceutical formulation containing gelling agent

#49 | 2015-09-24

US20150265606A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#50 | 2015-09-24

US20150265605A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#51 | 2015-09-24

US20150265604A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#52 | 2015-09-24

US20150265603A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#53 | 2015-09-24

US20150265602A1

Human necessities

Pharmaceutical formulation containing gelling agent

#54 | 2015-08-27

US20150238481A1

Human necessities

Pharmaceutical formulation containing gelling agent

#55 | 2015-08-20

US20150231131A1

Human necessities

Once-A day oxycodone formulations

#56 | 2015-08-20

US20150231086A1

Human necessities

Tamper-resistant oral opioid agonist formulations

#57 | 2015-07-02

US20150182628A1

Human necessities

Pharmaceutical formulation containing gelling agent

#58 | 2015-05-28

US20150148319A1

Human necessities

Pharmaceutical formulation containing gelling agent

#59 | 2015-05-28

US20150147391A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#60 | 2015-05-21

US20150140083A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#61 | 2015-04-16

US20150105467A1

Human necessities

FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN

#62 | 2015-01-29

US20150031718A1

Human necessities

Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent

#63 | 2015-01-01

US20150005333A1

Human necessities

Pharmaceutical formulation containing gelling agent

#64 | 2015-01-01

US20150005331A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#65 | 2014-12-18

US20140371257A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#66 | 2014-12-04

US20140357657A1

Human necessities

Pharmaceutical formulation containing gelling agent

#67 | 2014-08-14

US20140228390A1

Human necessities

Pharmaceutical formulation containing gelling agent

#68 | 2014-07-31

US20140213606A1

Human necessities

Pharmaceutical Formulation Containing Gelling Agent

#69 | 2014-07-03

US20140187572A1

Human necessities

Opioid dosage forms having dose proportional steady state Cand AUC and less than dose proportional single dose C

#70 | 2014-04-17

US20140107209A1

Human necessities

FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN

#71 | 2013-11-14

US20130303494A1

Human necessities

Pharmaceutical formulation containing gelling agent

#72 | 2013-10-03

US20130261145A1

Human necessities

Pharmaceutical formulation containing gelling agent

#73 | 2013-10-03

US20130261144A1

Human necessities

Pharmaceutical formulation containing gelling agent

#74 | 2013-10-03

US20130261143A1

Human necessities

Pharmaceutical formulation containing gelling agent

#75 | 2013-09-19

US20130245055A1

Human necessities

Pharmaceutical formulation containing gelling agent

#76 | 2013-08-22

US20130217716A1

Human necessities

Pharmaceutical formulation containing gelling agent

#77 | 2011-09-08

US20110218247A1

Human necessities

Formulations of low dose diclofenac and beta-cyclodextrin

#78 | 2009-03-26

US20090081287A1

Human necessities

Pharmaceutical composition containing gelling agent

#79 | 2008-06-05

US20080132532A1

Human necessities

Opioid dosage forms having dose proportional steady state Cand AUC and less than dose proportional single dose C

#80 | 2008-03-06

US20080054008A1

Human necessities

Dispensing device

#81 | 2008-01-24

US20080017658A1

Human necessities

Dispensing device

#82 | 2007-10-04

US20070232567A1

Human necessities

Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin

#83 | 2007-10-04

US20070232566A1

Human necessities

Formulations of low dose diclofenac and beta-cyclodextrin

InventorID:

403451 ⎘